In the most recent session, shares of Impax Laboratories Inc. (NASDAQ:$IPXL) dropped -$0.83, a volatility of -3.87%. Prices recently reached $20.62 on a volume of 3,190,000.
Some investors may value creating innovative and individual strategies for stock market supremacy. Traders with short-term mindsets are going to operate differently than those with long-term mindsets. Some may be right at home in the current bull market, whereas others may feel out of their depth. Focusing too much on dips and corrections may be useful in the short run, but often can leave investors with an incomplete picture.
With this in mind, let’s take a look at some of the stats for Impax Labs.
The Return on Assets is a profitability ratio that measures how much income is generated from a company’s total assets. The ratio is determined by taking net income and dividing it by total company assets. A higher ROA than a company in the same industry would reflect favorably on the company, whereas a company with a lower ROA would raise red flags. Impax currently has a ROA of -25.21.
We can also take a look at the Return on Invested Capital. The ROIC is determined by taking net income minus dividends and dividing it by total capital invested. This ratio demonstrates how competent a company is at using invested capital to generate profits. The company’s ROIC currently sits at -32.28.
Finally, we can take a look at Return of Equity. The ROE is a ratio that measures what sort of profits are generated from shareholder’s investments. As with the other ratios, a higher number reflects better on a company, while a lower number may raise red flags for potential investors. Impax currently has a ROE of -55.98.
Featured Image: facebook
